Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | smad1 5 8 and | 0.0019 | 0.0032 | 0.0068 |
Schistosoma mansoni | tar DNA-binding protein | 0.0141 | 0.4797 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0141 | 0.4797 | 1 |
Loa Loa (eye worm) | Smad1 | 0.0019 | 0.0032 | 0.0032 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0018 | 0 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0117 | 0.3872 | 0.3872 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0054 | 0.1418 | 0.1418 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.1418 | 0.2956 |
Toxoplasma gondii | isocitrate dehydrogenase | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.3872 | 0.3872 |
Echinococcus granulosus | smad | 0.0019 | 0.0032 | 0.0068 |
Brugia malayi | MH1 domain containing protein | 0.0019 | 0.0032 | 0.0032 |
Echinococcus granulosus | tar DNA binding protein | 0.0141 | 0.4797 | 1 |
Brugia malayi | MH1 domain containing protein | 0.0019 | 0.0032 | 0.0032 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0141 | 0.4797 | 0.4797 |
Echinococcus multilocularis | Smad4 | 0.0019 | 0.0032 | 0.0068 |
Brugia malayi | MH2 domain containing protein | 0.0019 | 0.0032 | 0.0032 |
Leishmania major | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1418 | 0.2956 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0171 | 0.5986 | 0.5986 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.1418 | 0.2956 |
Loa Loa (eye worm) | TAR-binding protein | 0.0141 | 0.4797 | 0.4797 |
Loa Loa (eye worm) | RNA binding protein | 0.0141 | 0.4797 | 0.4797 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0054 | 0.1418 | 0.2956 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1418 | 0.2956 |
Trypanosoma cruzi | isocitrate dehydrogenase, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | smad1 5 8 and | 0.0019 | 0.0032 | 0.0068 |
Echinococcus multilocularis | TGF beta signal transducer SmadC | 0.0019 | 0.0032 | 0.0068 |
Echinococcus multilocularis | GPCR, family 2 | 0.0054 | 0.1418 | 0.2956 |
Schistosoma mansoni | tar DNA-binding protein | 0.0141 | 0.4797 | 1 |
Plasmodium vivax | isocitrate dehydrogenase [NADP], mitochondrial, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0019 | 0.0032 | 0.0068 |
Schistosoma mansoni | Smad4 | 0.0019 | 0.0032 | 0.0068 |
Echinococcus multilocularis | tar DNA binding protein | 0.0141 | 0.4797 | 1 |
Echinococcus granulosus | TGF beta signal transducer SmadC | 0.0019 | 0.0032 | 0.0068 |
Echinococcus multilocularis | mothers against decapentaplegic 5 | 0.0019 | 0.0032 | 0.0068 |
Schistosoma mansoni | hypothetical protein | 0.0117 | 0.3872 | 0.8071 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0274 | 1 | 1 |
Trypanosoma brucei | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.5986 | 0.5986 |
Echinococcus granulosus | Smad4 | 0.0019 | 0.0032 | 0.0068 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0019 | 0.0032 | 0.0032 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0171 | 0.5986 | 0.5986 |
Echinococcus granulosus | GPCR family 2 | 0.0054 | 0.1418 | 0.2956 |
Schistosoma mansoni | smad1 5 8 and | 0.0019 | 0.0032 | 0.0068 |
Brugia malayi | MH2 domain containing protein | 0.0019 | 0.0032 | 0.0032 |
Schistosoma mansoni | tar DNA-binding protein | 0.0141 | 0.4797 | 1 |
Brugia malayi | Smad1 | 0.0019 | 0.0032 | 0.0032 |
Echinococcus granulosus | mothers against decapentaplegic 5 | 0.0019 | 0.0032 | 0.0068 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0054 | 0.1418 | 0.1418 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0171 | 0.5986 | 0.5986 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0018 | 0 | 0.5 |
Echinococcus multilocularis | smad | 0.0019 | 0.0032 | 0.0068 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0054 | 0.1418 | 0.1418 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1418 | 0.2956 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0141 | 0.4797 | 0.4797 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0274 | 1 | 1 |
Plasmodium falciparum | isocitrate dehydrogenase [NADP], mitochondrial | 0.0018 | 0 | 0.5 |
Trypanosoma cruzi | isocitrate dehydrogenase [NADP], mitochondrial precursor, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.1418 | 0.2956 |
Schistosoma mansoni | tar DNA-binding protein | 0.0141 | 0.4797 | 1 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0019 | 0.0032 | 0.0032 |
Trypanosoma brucei | isocitrate dehydrogenase, putative | 0.0018 | 0 | 0.5 |
Schistosoma mansoni | smad | 0.0019 | 0.0032 | 0.0068 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1418 | 0.1418 |
Brugia malayi | TAR-binding protein | 0.0141 | 0.4797 | 0.4797 |
Brugia malayi | RNA binding protein | 0.0141 | 0.4797 | 0.4797 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0054 | 0.1418 | 0.2956 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1.9 uM | Cytotoxicity against mouse BAF3 cells expressing Tel-ALK after 48 hrs by CellTiter-Glo assay | ChEMBL. | 21572589 |
IC50 (functional) | = 3.1 uM | Cytotoxicity against mouse BAF3 cells expressing EML4-ALK after 48 hrs by MTS assay | ChEMBL. | 21572589 |
IC50 (ADMET) | > 10 uM | Cytotoxicity against mouse BAF3 cells after 48 hrs by CellTiter-Glo assay | ChEMBL. | 21572589 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 21572589 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.